Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide (Revlimid) for POEMS syndrome
2008-003202-33Phase 2Completed
- Sponsor
- Humanitas Research Hospital
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lenalidomide in osteosclerotic myeloma (POEMS), sponsored by Humanitas Research Hospital. Primary endpoints: Clinical efficacy after 6 cycles and Safety of RD combination. Started Nov 2009; status: completed.
02
Drugs
lenalidomide
03
Conditions
osteosclerotic myeloma (POEMS)
Beyond the preview
Go deeper on 2008-003202-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003202-33.